Clinical Trial: Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema
Study Status: Completed
Recruit Status: RECRUITING
Condition: Alpha 1-Antitrypsin Deficiency
Study Type: INTERVENTIONAL
Official Title: Phase 2, Double-Blind, Randomized, Active-Control, Parallel Group Study to Assess the Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of INBRX-101 Compared to Plasma-Derived Alpha1-Prot
Brief Summary:
Phase 2 study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD emphysema
Read more